Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026)

Sarepta Therapeutics has reported Current Taxes for 8 years, with the latest figure at $13.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Taxes fell 82.73% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (down 82.73% YoY), and the FY2025 full-year result was $4.8 million, down 72.66% from the prior year.
• Current Taxes for Q1 2026 stood at $13.8 million, up from $4.8 million in the prior quarter.
• The five-year high for Current Taxes was $79.9 million in Q1 2025, with the low at $4.1 million in Q3 2022.
• Average Current Taxes over 5 years is $19.5 million, with a median of $16.1 million recorded in 2023.
• Year-over-year, Current Taxes surged 5696.76% in 2022 and plunged 82.73% in 2026.
• Tracing SRPT's Current Taxes over 5 years: stood at $12.5 million in 2022, then increased by 9.94% to $13.8 million in 2023, then climbed by 26.33% to $17.4 million in 2024, then tumbled by 72.66% to $4.8 million in 2025, then soared by 189.99% to $13.8 million in 2026.
• The last three Current Taxes figures came in at $13.8 million (Q1 2026), $4.8 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.

Peer Comparison